Sample size calculations for pathogen variant surveillance in the presence of biological and systematic biases.

SARS-CoV-2 infectious disease pathogen genomics pathogen variants sample size calculations variant surveillance variants of concern

Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
16 05 2023
Historique:
received: 05 09 2022
revised: 08 02 2023
accepted: 05 04 2023
medline: 19 5 2023
pubmed: 28 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Tracking the emergence and spread of pathogen variants is an important component of monitoring infectious disease outbreaks. To that end, accurately estimating the number and prevalence of pathogen variants in a population requires carefully designed surveillance programs. However, current approaches to calculating the number of pathogen samples needed for effective surveillance often do not account for the various processes that can bias which infections are detected and which samples are ultimately characterized as a specific variant. In this article, we introduce a framework that accounts for the logistical and epidemiological processes that may bias variant characterization, and we demonstrate how to use this framework (implemented in a publicly available tool) to calculate the number of sequences needed for surveillance. Our framework is designed to be easy to use while also flexible enough to be adapted to various pathogens and surveillance scenarios.

Identifiants

pubmed: 37105175
pii: S2666-3791(23)00132-5
doi: 10.1016/j.xcrm.2023.101022
pmc: PMC10213798
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101022

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Nat Commun. 2022 Nov 16;13(1):7003
pubmed: 36385137
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Cell. 2021 Dec 22;184(26):6229-6242.e18
pubmed: 34910927
PLoS Comput Biol. 2021 Jul 6;17(7):e1009182
pubmed: 34228722
Science. 2021 Aug 20;373(6557):889-895
pubmed: 34301854
J Travel Med. 2021 Oct 11;28(7):
pubmed: 34369565
Nature. 2021 May;593(7858):266-269
pubmed: 33767447

Auteurs

Shirlee Wohl (S)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. Electronic address: swohl@scripps.edu.

Elizabeth C Lee (EC)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Bethany L DiPrete (BL)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Justin Lessler (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; The Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Articles similaires

Humans Meta-Analysis as Topic Sample Size Models, Statistical Computer Simulation
Humans Disease Outbreaks Virginia Middle Aged Adolescent
Humans Disease Outbreaks Rivers COVID-19 Epidemiologists
1.00
Humans Female Mammaplasty Quality of Life Mastectomy

Classifications MeSH